This week, during Pancreatic Cancer Awareness Month, we are talking to Dr. Addison Tolentino, oncologist at Saint Luke’s Cancer Institute, about how genetic testing is expanding treatment options and a new screening test on the horizon that’s exciting doctors.
The HMC Foundation, the Chillicothe Police Department, and the Chillicothe R-2 School District are in partnership to re-start the D.A.R.E. (Drug Abuse Resistance Education) program in schools.
This week we are talking to Dr. Ginny Boos, Director of Infection Prevention, about vital things to keep in mind while traveling and tips to safely gather with family, friends, and those who are more vulnerable this holiday season.
Treating heart failure patients with canagliflozin significantly improves quality of life, with the marked benefit observed early and sustained through follow-up, according to the results of the CHIEF-HF trial.
New research reported at the AHA Scientific Sessions 2021 shows that the benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors on symptoms and quality of life in patients with heart failure extend to canagliflozin.
Carmon is living with type 2 diabetes, but her life is much fuller now because of the care she received at Saint Luke’s Cardiometabolic Center of Excellence.
Saint Luke’s Mercer County Clinic in Princeton, and Wright Memorial Physicians’ Group in Trenton, are pleased to welcome family practice physician, Jessica Snyder, MD, to the medical team.
